Frame Bio Secures Licensing for Innovative Drug Delivery Technology to Aid Regenerative Medicine Frame Bio has announced a strategic licensing agreement with Mercury Bio, gaining access to novel drug delivery technology aimed at treating bone and collagen disorders effectively.

Frame Bio Secures Licensing for Innovative Drug Delivery Technology to Aid Regenerative Medicine #United_States #Santa_Fe #Drug_Delivery #Frame_Bio #Mercury_Bio